FRM
Fox Run Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,330
| Closed | -$645K | – | 1276 |
|
|
2025
Q1 | $645K | Buy |
+1,330
| New | +$645K | 0.1% | 379 |
|
|
2024
Q3 | – | Sell |
-586
| Closed | -$275K | – | 1127 |
|
|
2024
Q2 | $275K | Buy |
+586
| New | +$275K | 0.05% | 573 |
|
|
2023
Q1 | – | Sell |
-2,578
| Closed | -$744K | – | 951 |
|
|
2022
Q4 | $744K | Buy |
2,578
+1,372
| +114% | +$396K | 0.3% | 62 |
|
|
2022
Q3 | $349K | Buy |
+1,206
| New | +$349K | 0.14% | 302 |
|
|
2022
Q1 | – | Sell |
-1,636
| Closed | -$359K | – | 722 |
|
|
2021
Q4 | $359K | Buy |
+1,636
| New | +$359K | 0.21% | 168 |
|
|
2020
Q1 | – | Sell |
-1,044
| Closed | -$229K | – | 377 |
|
|
2019
Q4 | $229K | Buy |
+1,044
| New | +$229K | 0.18% | 289 |
|
|
2018
Q4 | – | Sell |
-2,530
| Closed | -$488K | – | 749 |
|
|
2018
Q3 | $488K | Buy |
+2,530
| New | +$488K | 0.21% | 180 |
|
|
2018
Q1 | – | Sell |
-4,084
| Closed | -$612K | – | 946 |
|
|
2017
Q4 | $612K | Buy |
+4,084
| New | +$612K | 0.18% | 210 |
|
|
2017
Q3 | – | Sell |
-4,800
| Closed | -$619K | – | 886 |
|
|
2017
Q2 | $619K | Buy |
+4,800
| New | +$619K | 0.21% | 149 |
|
|
2016
Q4 | – | Sell |
-5,600
| Closed | -$488K | – | 691 |
|
|
2016
Q3 | $488K | Buy |
+5,600
| New | +$488K | 0.29% | 113 |
|
|
2016
Q2 | – | Sell |
-8,600
| Closed | -$684K | – | 681 |
|
|
2016
Q1 | $684K | Buy |
+8,600
| New | +$684K | 0.46% | 33 |
|